In those individuals with type 1 and type 2 diabetes who harbored detectable vaccine‐specific T cells, they displayed an unfocused, tolerogenic phenotype characterized by increased expression of IL‐10 and IL‐13 compared with people without diabetes. Here, IL13 is linked to type 2 diabetes mellitus.